Clinical Drug Experience Knowledgebase

anastrozole (arimidex) (1 trial)

apremilast (otezla) (1 trial)

cenicriviroc (1 trial)

elacestrant (Orserdu) (1 trial)

endoxifen (1 trial)

exemestane (aromasin) (1 trial)

ganetespib (1 trial)

ganitumab (1 trial)

icatibant (firazyr) (1 trial)

irinotecan (Camptosar) (1 trial)

letrozole (femara) (1 trial)

msk-2206 (1 trial)

nerlynx (1 trial)

patritumab (1 trial)

pembrolizumab (keytruda) (1 trial)

pertuzumab (perjeta) (1 trial)

pexidartinib (Turallo) (1 trial)

razuprotafib (1 trial)

remdesivir (Veklury) (1 trial)

sitagliptin (januvia) (1 trial)

talazoparib (talzenna) (2 trials)

tamoxifen (nolvadex) (1 trial)

testosterone (delatestryl) (1 trial)

trastuzumab (herceptin) (1 trial)

trastuzumab emtansine (kadcyla) (1 trial)

trebananib (1 trial)

veliparib (1 trial)

alx148 (1 trial)

carboplatin (paraplatin) (1 trial)

fam-trastuzumab deruxtecan-nxki (Enhertu) (1 trial)

paclitaxel (taxol) (1 trial)

syd985 (1 trial)

tucatinib (Tukysa) (1 trial)

zw25 (1 trial)